NCT00158496View on ClinicalTrials.gov

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

January 31, 2005

Conditions

Chronic Hepatitis C

Interventions

DRUG

pegylated interferon alpha2a

DRUG

ribavirin

Trial Locations (2)

Unknown

Ismail Sallam hospital, Zawiat Razin

National Hepatology and Tropical Medicine Research Institute, Cairo

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00158496 - Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211) | Biotech Hunter | Biotech Hunter